(Q34253944)

31 July 2017

1 reference

title

Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies (English)

1 reference

31 July 2017

Sirica AE

1

1 reference

31 July 2017

Lai GH

series ordinal

2

1 reference

31 July 2017

Zhang Z

series ordinal

3

1 reference

31 July 2017

language of work or name

1 reference

1 April 2001

1 reference

Journal of Gastroenterology and Hepatology

31 July 2017

1 reference

31 July 2017

16

1 reference

31 July 2017

4

1 reference

31 July 2017

363-372

1 reference

Risk factors for biliary tract carcinogenesis

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

21 January 2018

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Histochemical and immunohistochemical studies on development of biliary carcinoma in forty-seven patients with choledochal cyst--special reference to intestinal metaplasia in the biliary duct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Expression of an intestine-specific transcription factor (CDX1) in intestinal metaplasia and in subsequently developed intestinal type of cholangiocarcinoma in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Biliary proliferation and adaptation in furan-induced rat liver injury and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Establishment of a novel rat cholangiocarcinoma cell culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Characterization and growth regulation of a rat intrahepatic bile duct epithelial cell line under hormonally defined, serum-free conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Hepatocyte growth factor up-regulates met expression in rat fetal hepatocytes in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Cyclooxygenase-1 and -2 isoenzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

The role of COX-2 in intestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Establishment of a functional HGF/C-MET autocrine loop in spontaneous transformants of WB-F344 rat liver stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Regulation of cyclooxygenase-2 pathway by HER2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

Perceptions of Herceptin: a monoclonal antibody for the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02438.X

10.1046/J.1440-1746.2001.02438.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference